Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,145 public trials 553 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy

NCT00004985

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Phoenix Body Positive Phoenix, Arizona, United States
  • Pacific Oaks Med Group Beverly Hills, California, United States
  • First Choice Medical Palm Springs, California, United States
  • Apogee Med Group San Diego, California, United States
View all 34 locations
View Trial Details
Completed

The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT

NCT00002436

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Combat Group Los Angeles, California, United States
  • San Diego Community Research Group San Diego, California, United States
  • ViRx Inc San Francisco, California, United States
  • AIDS Research Consortium of Atlanta Atlanta, Georgia, United States
View all 22 locations
View Trial Details
Completed

A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)

NCT00002014

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States
  • Univ of Miami School of Medicine Miami, Florida, United States
  • New England Med Ctr Boston, Massachusetts, United States
  • Univ of Washington Seattle, Washington, United States
View Trial Details
Completed

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

NCT00000846

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Univ of Rochester Med Ctr Rochester, New York, United States
  • Univ of Washington / Pacific Med Ctr Seattle, Washington, United States
View Trial Details
Completed

A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines

NCT00002402

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Dr Frank Judson / Director of Public Health Dept Denver, Colorado, United States
  • Johns Hopkins Bloomberg School of Public Health Washington D.C., District of Columbia, United States
  • Fenway Community Health Ctr Boston, Massachusetts, United States
  • Saint Louis Univ Health Sciences Ctr St Louis, Missouri, United States
View Trial Details

Related conditions